Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunome Inc.

9.13
+0.01000.11%
Post-market: 9.130.00000.00%17:36 EDT
Volume:1.23M
Turnover:11.25M
Market Cap:794.42M
PE:-2.92
High:9.55
Open:9.24
Low:8.92
Close:9.12
Loading ...

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
15 Mar

Immunome Initiated at Outperform by LifeSci Capital

Dow Jones
·
11 Mar

Immunome initiated with an Outperform at LifeSci Capital

TIPRANKS
·
11 Mar

BRIEF-Immunome doses first patient in early-stage trial of its experimental cancer treatment

Reuters
·
10 Mar

Immunome Doses First Patient in Phase 1 Trial of IM-1021, a Ror1-Targeted ADC

THOMSON REUTERS
·
10 Mar

Immunome Doses First Patient in Phase 1 Trial of IM-1021, a ROR1-Targeted ADC

Business Wire
·
10 Mar

Immunome to Present at Upcoming March Conferences

Business Wire
·
25 Feb

Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
07 Feb

Immunome Closes Public Offering of Shares

MT Newswires Live
·
01 Feb

Immunome Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Business Wire
·
01 Feb

BUZZ-Immunome drops on $150 mln stock sale

Reuters
·
30 Jan

Immunome Prices $150 Million Stock Offering

MT Newswires Live
·
30 Jan

Immunome 19.35M share Spot Secondary priced at $7.75

TIPRANKS
·
30 Jan

BRIEF-Immunome Says Prices Public Offering Of 19.4 Mln Shares At $7.75 Per Share

Reuters
·
30 Jan

Immunome Inc - Expects Gross Proceeds of $150 Million From Offering

THOMSON REUTERS
·
30 Jan

Immunome Announces Pricing of Upsized Public Offering of Common Stock

THOMSON REUTERS
·
30 Jan

Immunome Inc - Prices Public Offering of 19,354,839 Shares at $7.75 per Share

THOMSON REUTERS
·
30 Jan

BRIEF-Immunome Announces Proposed Public Offering Of Common Stock

Reuters
·
30 Jan

Immunome $125M Spot Secondary; price range $7.50-$8.00

TIPRANKS
·
30 Jan

BUZZ-Immunome drops on stock offering

Reuters
·
30 Jan